People with sickle cell disease often struggle with memory, focus, learning and problem solving, setting them back in ...
Health workers in the eastern district of Budaka in Bukedi Sub-region have registered a decline in cases of sickle cell disease that had deeply affected families and communities in the district.
However, carriers can have children who inherit sickle cell disease and may exhibit symptoms. Therefore, unless you conduct DNA paternity tests that confirm the child is not yours, the fact that ...
Rigel Pharmaceuticals has enrolled the first subject in a Phase I trial of its oral spleen tyrosine kinase (SYK) inhibitor, fostamatinib, to treat sickle cell disease (SCD). The trial aims to assess ...
A National Academies consensus study committee funded by the Social Security Administration will host the second in a series of public, information-gathering webinars including the perspectives of ...
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...
June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...
The breakthrough science focused on replicating heart ... Fatty Muscles Raise the Risk of Serious Heart Disease Regardless of Overall Body Weight Jan. 19, 2025 — People with pockets of fat ...
The push to regard addiction as a disease is well-intentioned—driven by a desire to lessen stigma—but fails to account for the many facets and facts of the condition. Worse, it robs sufferers ...
Alzheimer's disease is a progressive neurodegenerative disease that impairs memory and cognitive judgment and is often accompanied by mood swings, disorientation and eventually delirium.
Chronic conditions, on the other hand, are long-lasting. They develop and potentially worsen over time (e.g., Crohn's disease). These descriptions can vary somewhat, though, depending on who you speak ...